Tyson Foods Is Playing a Game of COVID Chicken With China

Photo of Chris Lange
By Chris Lange Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Tyson Foods Is Playing a Game of COVID Chicken With China

© Courtesy of DreamWorks Animation

Tyson Foods Inc. (NYSE: TSN | TSN Price Prediction) took a hit on Monday after it came to light that China’s customs agency has suspended poultry imports from one of the company’s facilities in Arkansas. The suspension is COVID-19 related.

The facility in question is located in Springdale, Arkansas.

A spokesperson for Tyson noted that all global and U.S. health agencies, including the U.S. Food and Drug Administration, have said that there is no evidence to support the transmission of COVID-19 via food.

However, the root of the problem comes from the COVID-19 cases that have gripped the Springdale facility. After conducting coronavirus testing at this facility, Tyson found that 481 out of 3,748 tested positive, and about 95% of the positives were asymptomatic.

Note that this isn’t the first Tyson facility that has seen an outbreak of cases. There have been outbreaks in North Carolina, Nebraska and Iowa facilities as well.

[nativounit]

This move by China comes after it lifted a five-year ban on U.S. poultry in November. China originally blocked U.S. poultry imports after an outbreak of avian influenza in December 2014. Note that China had bought more than $500 million in American chicken and turkey, among other poultry, in 2013.

The new (current) outbreak in China is being blamed on imported salmon. Contract tracing tacked the coronavirus clusters to a chopping board used by a fish seller. Ultimately, this has led China to boycott salmon altogether.

Chicken may be next on the menu.

Tyson Foods stock traded down over 2% to $61.58 on Monday, in a 52-week range of $42.57 to $94.24. The consensus price target is $72.72.

[recirclink id=714773][wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618